News

Rising energy prices in Europe run the risk of accelerating the migration of businesses necessary for the production of life-saving medications, further jeopardising the pharma supply chains that were already struggling under the worst of COVID-19. Essential medications are important...

In 2021, the market for third-party logistics for the biopharmaceutical industry was estimated to be worth USD 117.25 billion. By 2030, it is expected to have grown to USD 195.75 billion, with a CAGR of 5.86% from 2022 to...

Your health comes first. Consequently, you don't mind spending more to buy all the supplements your doctor recommended. But you might face a financial crisis soon if you're not careful about the amount you've allocated to supplements. It's even worse...

The healthcare industry is undergoing a massive transformation. According to Statista, it's an industry that grew at a rate of 15.9% within five years from 2016, projected to reach USD$59.70 billion in 2022. Sure, the influence of technology is...

Deals can be just as significant in the drug development industry as scientific advancements. Without mergers and acquisitions, many of today's most significant pharmaceuticals—from the anti-inflammatory Humira to the life-saving cancer medication Keytruda—might not have come to be. Pharmaceutical M&A...

According to new research, ancient infections that left viral DNA in human genomes act as antivirals to shield human cells from some modern viruses. A Science article titled Evolution and Antiviral Activity of a Human Protein of Retroviral Origin offers...

On October 28th, an advisory board to the European Medicines Agency advised restricting the use of a class of medications for inflammatory diseases due to a known association with side effects like cancer and heart attacks. The group recommended limiting...